Next Article in Journal
Melatonin Prevents Oxidative Stress-Induced Mitochondrial Dysfunction and Apoptosis in High Glucose-Treated Schwann Cells via Upregulation of Bcl2, NF-κB, mTOR, Wnt Signalling Pathways
Next Article in Special Issue
Coordination Complex Formation and Redox Properties of Kynurenic and Xanthurenic Acid Can Affect Brain Tissue Homeodynamics
Previous Article in Journal
Antioxidant and Adaptative Response Mediated by Nrf2 during Physical Exercise
Previous Article in Special Issue
Effect of Side Chain Functional Groups on the DPPH Radical Scavenging Activity of Bisabolane-Type Phenols
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 8
Issue 6
10.3390/antiox8060197
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of the Antioxidant Activity of Cis/Trans-N-Phenyl-1,4,4a,5,8,8a-Hexahydro-3,1-Benzoxazin-2-Imines

by
Guadalupe Firpo
1,
María L. Ramírez
1,
Martín S. Faillace
1,
Maria dos R. Mendes de Brito
2,
Ana P. S. Correia Lima e Silva
3,
Jessica Pereira Costa
2,
Marcela C. Rodríguez
1,
Gustavo A. Argüello
2,
Zsolt Szakonyi
4,*,
Ferenc Fülöp
4 and
Walter J. Peláez
1,*
1
INFIQC-CONICET. Departamento de Físicoquímica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, X5000HUA Córdoba, Argentina
2
Department of Pharmaceutical Chemistry, Faculty of Facid Wyden, Federal University of Piauí, Teresina, PI. CEP 64.052-410, Brazil
3
Department of Pharmaceutical Chemistry, Faculty of Nursing, Federal University of Piauí, Teresina, PI. CEP 64.049-550, Brazil
4
Institute of Pharmaceutical Chemistry, University of Szeged, H-6720 Szeged, Eötvös utca 6, Hungary
*
Authors to whom correspondence should be addressed.
Antioxidants 2019, 8(6), 197; https://doi.org/10.3390/antiox8060197
Submission received: 1 May 2019 / Revised: 12 June 2019 / Accepted: 21 June 2019 / Published: 25 June 2019
(This article belongs to the Special Issue The Chemistry of Antioxidant Activity)
Browse Figures
Versions Notes

Abstract

:
The growing interest in the chemistry of unsaturated ring-fused 1,3-heterocycles, in this particular case 1,3-oxazines, arise in part from their versatile pharmacological applications. In the present article, the evaluation of the in vitro and ex vivo antioxidant activity of two cyclohexene-fused oxazines is discussed. The in vitro antioxidant activity was evaluated by trapping the ABTS and hydroxyl radicals as well as the inhibition of the enzyme acetyl-cholinesterase and hemolysis of erythrocytes by 2,2’-Azobis(2-amidinopropane) dihydrochloride (AAPH). The results suggest that both unsaturated 1,3-oxazines are auspicious sources of biologically active compounds with good antioxidant properties. In addition, a comprehensive analysis of the interaction between these heterocycles with 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radicals, as well as the measurements of redox potential, provided evidence for a mechanism of antioxidant activity that takes place through electron transfer (ET) processes.

Graphical Abstract

1. Introduction

Free radicals are responsible for intercellular signaling and synthesis of important biological substances in living organisms, due to their ability to facilitate the donation of their electrons to other molecules, which causes chain reactions [1,2]. However, some free radicals, called reactive oxygen species (ROSs), as well as other radical promoters, are extremely harmful leading to deleterious effects such as DNA, proteins and cell organelles damage [3,4,5,6,7]. ROSs such as superoxide (O2●), hydroxyl (OH●) and hydrogen peroxide (H2O2) are generated by the oxygen metabolism pathway [8].
Some physiological processes are responsible for the antioxidant defense mechanism that catalyzes the reduction of O2 in water. Such processes control the generation of free radicals and prevent their overproduction in mitochondria [9]. However, there are some diseases where oxidative stress is involved in the pathophysiology, and often, the defense mechanism is not enough. In these cases, it is necessary to find new antioxidant compounds as therapeutic agents [10].
Studies conducted with synthetic compounds have shown good results in the field of antioxidant capacity. Among these groups of substances, oxazines have played an important role due to their wide pharmacological applications. In this sense, the derivative 2-ethoxy-4,5-diphenyl-1,3-oxazine-6-one exhibit a neuroprotective effect in rat pheochromocytoma cells against cellular death induced by H2O2 [11]. Similarly, 1,3-oxazine substituted 9-anilinoacridine derivatives [12] and bi- and tetra-substituted dihydro-1,3-oxazines [13] were evaluated for their antioxidant activities. In addition, the derivative tetrahydro-1,4-oxazine is known to be biologically active against enzymes that metabolize inflammatory drugs [2].
As part of our ongoing research on partially saturated 1,3-heterocycles [14,15,16,17,18], we have published the synthesis of cyclohexene-fused 1,3-oxazines with selective antibacterial and antiparasitic action along with low cytotoxic effects (compounds 1, 2, Figure 1) [19].
Finding new compounds with antioxidant activity is of utmost importance, this new study aims to evaluate the antioxidant potential of these synthetic oxazines through in vitro and ex vivo methodologies. The deep interest in the antioxidant behavior of these compounds arises in part from their versatile synthetic applicability and their potential pharmacological applications [15,20,21,22,23,24,25].
In order to measure antioxidant activity, different techniques and procedures have been proposed. Depending on the reactions involved, in vitro assays can roughly be classified into two types: assays based on hydrogen atom transfer (HAT) and assays based on electron transfer (ET). HAT-based assays measure the capability of an antioxidant to quench free radicals by H-atom donation. On the other hand, ET-based assays measure the capacity of an antioxidant in the reduction of an oxidant, which changes color when reduced [26]. The results obtained by HAT and ET based assays are hardly comparable because of the different driving mechanisms, redox potentials, pH and solvent dependencies between them [27]. Other types of antioxidant assays are based on lipids oxidation, which is a key issue mainly in food deterioration and oxidative modification of low-density lipoprotein (LDL) [28]. Some examples of these assays are the hemolysis potential and thiobarbituric acid reactive substances (TBARS) analysis.
In this work, in vitro antioxidant properties of oxazines (1,2) were evaluated by inhibition of 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS●+), OH●, 2,2-diphenyl-1-picrylhydrazyl (DPPH●) and the enzyme acetylcholinesterase (AChE). In addition, through electrochemical assays, oxidation redox potential was also measured. At the same time, control substances like trolox (Tx), ascorbic acid (AAc) and hydroquinone sulfonic acid (HQSAc) were also tested and used as the simplest target to elucidate the possible mechanisms occurring and to determine the antiradical power (ARP) along with the stoichiometry of the reactions. Furthermore, ex vivo antioxidant activity was measured by testing the hemolysis inhibition of rat erythrocytes after induction by 2,2’-azo-bis(amidinopropane) dihydrochloride (AAPH).

2. Materials and Methods

2.1. Evaluation of in Vitro Antioxidant Potential by Inhibition of ABTS●+ Radical

The methodology described by Re et al. [29] was used for the determination of the antioxidant capacity by the ABTS●+ method. Initially, the ABTS●+ radical cation was formed from the reaction of 2,2’-azino-bis(3-ethylbenzothyazoline-6-sulfonic acid (ABTS in water, 5 mL, 7 mM) with potassium persulfate (K2S2O8 in water, 88 µL, 2.45 mM) and incubated in darkness for 16 h at room temperature. Then, the solution of ABTS●+ was diluted in ethanol to obtain an absorbance of 0.70 ± 0.05 at 734 nm and 1960 µL were fed in each of ten test tubes keeping the dark conditions. Different aliquots of oxazines 1 and 2 were added to this solution to reach final concentrations of 9.0, 13.5, 18.0, 22.5 and 27.0 µg/mL and after 6 min, the absorbance was measured at 734 nm. The results, expressed as percentages of ABTS●+ radical inhibition were taken from Equation (1), and from their values, the effective inhibitory concentration (EC50) at 734 nm was determined. The same experimental procedure was used with the standard positive control Tx.
% inhibition of ABTS●+ = {(Acontrol − Areaction mixture) × 100}/Acontrol
Acontrol is the initial absorbance of the ethanol solution of ABTS●+.

2.2. Evaluation of In Vitro Antioxidant Potential Measured against the Production of Hydroxyl Radical

For the evaluation of the antioxidant potential, measured against the production of OH● generated by the Fenton reaction, the methodology described by Lopes et al. [30] with some modifications was used. Different aliquots of oxazines 1 and 2 were added to 300 µL of Fenton reaction mixture, which contains FeSO4 (6 mM), 2-deoxyribose (5 mM), H2O2 (100 mM) and phosphate buffer (20 mM, pH 7.4) in order to reach final concentrations of 9.0, 13.5, 18.0, 22.5 and 27.0 µg/mL. The reaction was allowed to proceed for 15 min at room temperature and then 4% phosphoric acid followed by 1% thiobarbituric acid (TBA in NaOH 50 mM) were added. Then, the mixture was heated for 1 h at 37 °C and finally cooled down to room temperature. The experiment was performed by triplicate and the absorbance readings measured at 532 nm. The results were expressed as a percentage of 2-deoxyribose degradation. The effective inhibitory concentration of the compound required to inhibit the degradation of 2-deoxyribose by 50% (EC50) was determined at 532 nm. The same experimental procedure was also used with the positive control Tx at the same set of concentrations.

2.3. Evaluation of In Vitro Antioxidant Potential by Inhibition of DPPH Radical

The antioxidant activities of different compounds against DPPH● were performed following the procedures described by Brand-Williams et al. [31]. Different concentrations of each tested compound in ethanol (0.1 mL), were added dropwise to 3.9 mL of DPPH● solution (6×10−5 mol L−1 in ethanol) and the absorbance decay was measured at 517 nm at t = 0, 1 and every 15 min until the reaction reached a plateau. The initial DPPH● concentration was determined by a calibration curve. For each antioxidant concentration tested, the percentage remaining of DPPH● was plotted against time. From these plots, the percentage of DPPH● at the steady state (at each antioxidant concentration) was determined. These values were transferred onto another graph and plotted as a function of the molar ratio of antioxidant to DPPH● (moles antioxidant/mole DPPH●) to determine, the rEC50 which is the relative amount necessary to decrease the initial DPPH● concentration to 50%.

2.4. Evaluation of the Qualitative Inhibition of the Enzyme Acetylcholinesterase

The inhibitory activity of the enzyme was controlled using the methodology proposed by Rhee et al. [32], who adapted the procedure established by Ellman et al. [33]. Initially, the compounds to be analyzed were dissolved in methanol and then spotted on a thin layer chromatography (TLC) plate. The compounds were eluted with a mixture of chloroform and methanol (9:1). Then, the plate was sprayed with 5,5’-dithio-bis[2-nitrobenzoic acid] (DTNB) and acetylthiocholine iodide in Tris-HCl buffer (pH 8). Five minutes later, the enzyme AChE was sprayed and the inhibition was observed. For these experiments, caffeine was used as a positive standard [34].

2.5. Test of Hemolysis Inhibition in Erythrocytes of Rattus norvegicus Induced by AAPH

To evaluate the antioxidant capacity by hemolysis inhibition of rat erythrocytes (R. norvegicus, Wistar type), the methodology described by Ugartondo et al. [35] with some modifications was used. Animal care followed the official governmental guidelines in compliance with the Society Policy and was submitted by the Ethics Committee of the Federal University of Piauí [36]. Briefly, an erythrocyte suspension (200 µL) and a solution of AAPH (100 µL, 20 nM) in PBS (Phosphate Buffered Saline, MERK KGaA, Darmstadt, Germany, pH 7.4), were mixed with oxazines 1 or 2 in order to reach a final concentration of 100 µg/mL. Simultaneously, a control was set to detect the spontaneous hemolysis. The reaction mixture was incubated at 37 °C for 30 min followed by a centrifugation step performed at 2500 rpm for 5 min. Then, PBS (800 µL) was added to the supernatant obtained (200 µL) in order to determine hemolysis by measuring the absorbance at 540 nm. The same experimental procedure was also used with the standard positive control Tx.
The results were expressed as percentage of hemolysis inhibition using an equation similar to Equation (1), where the Acontrol corresponds now to the hemolysis absorbance of 2% erythrocytes suspension induced by AAPH (100% hemolysis). The erythrocytes suspension in PBS was taken as 0%.

2.6. Determination of Redox Potential

Certainly, one of the most powerful, simple and frequently used electrochemical techniques (often along with DPPH● assay) for the determination of the antioxidant activity is cyclic voltammetry (CV) [37,38]. The experimental procedure consists in applying a potential scan from a starting value to a final one, and then returning to the initial potential, while the current flowing between working and counter electrodes is being registered. The potential at which the current increases shows a signal with a peak shape, which corresponds to the oxidation or reduction process of a species in solution. In this way, the oxidation potential can be taken as a measure of the easiness of the oxidation process. Thus, low values of oxidation potentials of a given compound are associated with a greater facility for electro-donation and, therefore, antioxidant activity of such compound [39,40].
Electrochemical experiments were performed with a TEQ_04 potentiostat. Glassy carbon electrodes (3 mm diameter, CH Instruments, Inc. Austin, TX USA) were used as working electrodes. A platinum wire and Ag/AgCl, 3 M NaCl (BAS, Model RE-5B, BASi® Corporate Headquarters, West Lafayette, IN, USA) served as counter and reference electrodes, respectively. All potentials were referred to the later. The electrodes were inserted into a conventional electrochemical cell through holes in its Teflon cover. When the experiment required it, the solution was deoxygenated with ultrapure N2. For the subsequent analysis, OriginPro 8.0 software (OriginPro 8.0, OriginLab Corporation, Northampton, MA, USA) was used.

2.7. Statistical Analysis

The results, that follow a parametric distribution, were evaluated by analysis of variance (ANOVA) and the Student-Newman-Keuls test as post hoc test. For nonparametric data (percentages), the chi-square test was used (GraphPad PRISM® 6.0 software, GraphPad Software Inc, San Diego, CA, USA). The differences were considered statistically significant for p < 0.05. Also, the EC50 values and its confidence intervals (95%) for the experiments were obtained using the same GraphPad Prism software.

3. Results

3.1. In Vitro Antioxidant Potential against the Production of Hydroxyl Radical

The effect of 1 and 2 on the inhibition of OH● is shown in Figure 2. Both oxazines were able to act as inhibitors of the degradation of 2-deoxyribose by removing significantly the amount of hydroxyl radical (p < 0.05) compared to the positive control Tx, (Figure 2). In the concentration range of 9.0 to 27.0 µg/mL, compound 1 showed antioxidant capacity values from 71 to 78.5%, while the antioxidant capacity of 2 ranged from 69.1 to 79.6%. Nevertheless, the positive control showed antioxidant capacity from 24 to 82%, as seen in Table 1. Upon these results for inhibition of the degradation of 2-deoxyribose, the EC50 values calculated with the statistical treatment were 0.48 µg/mL, 1.28 µg/mL and 15.21 µg/mL for compounds 1, 2 and Tx, respectively.

3.2. In Vitro Antioxidant Potential by Inhibition of ABTS●+ Radical

The antioxidant results related to the capture of ABTS●+ radical by 1 and 2 at different concentrations are shown in Figure 3. The values of antioxidant capacity of both oxazines, at the same concentrations employed for the OH● tests, were in the range of 32.0 to 40.8% and 38 to 46.6%, respectively, (Table 2). The oxazine 2 significantly reduced (p < 0.05) the concentration of ABTS●+ compared to the positive control Tx. In addition, Tx showed antioxidant capacity range value of 36.5 to 41.3%, at the same concentration of 1 and 2. Based on these results, the EC50 values (and rEC50 calculated as moles of antioxidant/mole ABTS●+) were 66.5 µg/mL (0.45), 36.0 µg/mL (0.34) and 34.3 µg/mL (0.30) for oxazine 1, 2 and Tx respectively. In the same order the ARP values calculated as 1/rEC50, were 2.2, 2.9 and 3.3.

3.3. Hemolysis Inhibition in Erythrocytes of Rattus norvegicus Induced by AAPH and Qualitative Inhibition of the Enzyme Acetylcholinesterase

The results of hemolysis inhibition induced by AAPH (20 nM) in an erythrocytes suspension in the presence of 1 and 2 is shown in Figure 4. The values of the antioxidant activity at the concentration of 100 µg/mL were (69 ± 2%, p < 0.05) and (57.1 ± 0.6%, p < 0.05), respectively. As it is possible to see, both oxazines decrease significantly the hemolysis effect compared to AAPH. Tx at 100 µg/mL, also reduced the percentage of hemolysis significantly (79 ± 5%, p < 0.05) compared to AAPH. Finally, as indicated in the experimental section, we also tested the qualitative inhibition of the enzyme AChE with the oxazines, obtaining in both cases positive results.

3.4. Cyclic Voltammetry

The redox behavior of the synthesized oxazines 1 and 2 was evaluated using cyclic voltammetry (CV) (Figure 5), recording the voltammograms in buffer phosphate 0.050 M pH 7.40 and comparing the electrochemical behavior of oxazines 1 and 2 to that of reference compounds Tx, AAc and HQSAc. These substances are well-known for either having antioxidant activity (Tx and AAc) or a structure that some authors considered as potentially good antioxidants (HQSAc) [41]. In this sense, oxazines 1 and 2, due to their chemical structure, could be classified into the last group. For a better analysis, the oxidation and reduction peak potentials (denoted as Eap and Ecp, respectively) and the difference (∆Ep) expressed as the absolute value of the difference between Ecp and Eap, were evaluated as well. In Figure 5A it is possible to see that the voltammetric responses for Tx, AAc and HQSAc show well-defined redox profiles. As it was expected, the lowest Eap is observed for Tx (0.123V), being 0.322 V and 0.367 V the results obtained for AAc and HQSAc, respectively. However, for oxazine 1 and 2 the redox processes are negligible, even at higher concentrations, which suggest that the electron transfer processes of these compounds are certainly impeded. In order to dilucidate the redox behavior of oxazines 1 and 2, it was necessary to set a new wider potential window from −1.20 V to 0.90 V. Under these new conditions, the characteristic redox process of oxygen could be an important interference in the determination of the reduction potentials of oxazine 1 and 2. Therefore, the deoxygenation of the solution was required. As it can be seen in Figure 5B, the oxidation potentials for oxazine 1 and 2 were 0.420 and 0.380, respectively.
The values of ∆Ep were obtained in separated experiments for each compound and performed in a three-electrode conventional electrochemical cell using a glassy carbon working electrode (other conditions as detailed in experimental section). The ∆Ep found values were 0.076 V and 0.273 V for Tx and HQSAc, respectively (Figure 5A). The ∆Ep value for AAc could not be calculated due to the existence of a unique peak for the oxidation process because of its irreversible behavior under the tested conditions. The ∆Ep values for oxazine 1 and 2 where 0.979 V and 0.939 V, respectively (Figure 5B). These results indicate that the glassy carbon working electrode surface is less reactive for the heterogeneous redox processes of oxazine 1 as well as 2 presenting a kind of limitation in comparison with the reference compounds.

3.5. In Vitro Antioxidant Potential by Inhibition of DPPH● Radical

The antioxidant abilities were determined using DPPH● as a free radical. For each antioxidant, different concentrations were tested (expressed as the number of moles of antioxidant/mole DPPH●) and the reaction response curves were plotted, (Figure 6, left). From these results, the relative efficient concentration (rEC50) and the antiradical power (ARP = 1/rEC50) were determined: the increase of the ARP infers a higher efficient antioxidant ability, (Figure 6, right).
As expected, Tx and AAc have a very good response reaching a steady state in less than 2 min and their ARPs were 4.9 and 4.4, (Figure 6a,b, respectively). On the other hand, HQSAc shows an intermediate behavior, where the steady state was reached after approximately 20 min and its ARP was 3.6, (Figure 6c). Apparently, oxazines 1 and 2 do not react with DPPH● after 4 h, as it is possible to see in Figure 6d for oxazine 1. Nevertheless, it has been reported that some compounds, like guaiacol and its derivatives, have delayed responses in these kinds of assays, taking approximately 6 h to reach the steady state [31]. From a deeper analysis of the oxazine 1 reaction response plots (local enlargement in Figure 6d), it is possible to observe that it reacts very slowly, demonstrating a negligible antioxidant ability, in spite of the results obtained from the other tests performed in this work. A similar behavior could be observed from the analysis of 2 (data not shown).

4. Discussion

The biology of free radicals is an emerging area, which mainly explores the formation and elimination of these harmful compounds, as well as the damage they produce on biological systems. It is established that a number of radicals centered in free oxygen and other ROSs contribute to the pathology of many disorders, including atherogenesis, neurodegeneration, chronic inflammation [42,43], cancer and physiological senescence [44]. Due to this, there is an increasing interest in antioxidant processes as a way to aid in the treatment of diseases associated with free radicals.
The OH● radical is one of the most deleterious free radicals because its half-life is very short and can hardly be captured in vivo. This radical often attacks molecules through hydrogen abstraction and it can be generated by reaction of H2O2 with transition metals or through homolysis of water by exposure to ionizing radiation [4]. The in vitro antioxidant capacity of 1 and 2 against the production of hydroxyl radical is demonstrated by the Fenton reaction. Both oxazines gave remarkable results, i.e., 1, EC50 = 0.48 µg/mL and 2, EC50 = 1.28 µg/mL compared with the standard Tx (EC50 = 15.21 µg/mL). It is important to highlight that even at the lowest dose of oxazines tested (9.0 µg/mL), they showed a higher reduction of radicals than the standard Tx (9.0–22.5 µg/mL).
The in vitro antioxidant capacity was also determined by studying the trapping of ABTS●+. This study demonstrated that 1 and 2 are efficient antioxidants for the effective removal of the ABTS●+ radical. It is important to note, that both heterocycles showed good antioxidant capacity, showing oxazine 2 an ARP (2.9) similar to Tx (3.3). The antioxidant capacity of these two substances was proportional to the concentration.
The inhibition assay of the AchE was qualitatively demonstrated. This fact is visibly revealed by the color change of the sample from yellow to white in the chromatographic plate. The achieved results are in accordance with Sukhorukov’s observation [2], who demonstrated that 1,3-oxazines, representatives of the library that they prepared, were capable to inhibit the activity of the enzyme AchE.
Alternatively, the in vitro antioxidant capacity was also explored for possible ex vivo protection of biomolecules from damage caused by free radicals [45]. For this evaluation, oxazines 1 and 2 were tested ex vivo using erythrocyte of Rattus norvegicus. The erythrocytes are particularly susceptible to oxidative injury due to the high polyunsaturated fatty acid content of their membranes and the high cellular oxygen and hemoglobin (Hb) concentrations. Exposure of erythrocytes to free radicals lead to damage of cell membrane (lipid peroxidation), changes in cellular morphology, protein cross-linking, and sulfhydryl group oxidation, which can subsequently result in membrane damage and hemolysis [46]. Therefore, because of its susceptibility to oxidation, erythrocytes have been used as cell models to investigate oxidative damage on biomembranes [47]. According to the results described above, oxazines 1 and 2 were able to protect erythrocytes from damage induced by AAPH, since there was a decrease in the hemolysis of rat erythrocytes.
On the other hand, two complementary assays were employed to shed light about the mechanism operating in the antioxidant ability of the studied compounds (Table 3). It is well known that ABTS●+ tests go through an ET process while DPPH● assay was believed to only involve HAT mechanism. However, evidence provided by experts in the area [48,49,50], have amply demonstrated that DPPH● can be quenched by both electron and atom transfer. As it was expected, analysis of the results shows that Tx possesses the highest antioxidant activity/capacity (ARP = 4.9 and 3.3 for DPPH● and ABTS●+ determinations, respectively; entry 1 Table 3). In the same way, ARP values obtained for oxazines 1 and 2 by the ABTS●+ test were slightly lower than for Tx, (entries 2 and 3 Table 3), indicating that both oxazines have good antioxidant capacity. Nevertheless, no parameters could be determined by the DPPH● technique, due to delayed response of these oxazines.
In addition, the electrochemical behavior was evaluated trough cyclic voltammetry experiments. The results obtained from these experiments were anodic and cathodic peak potentials (Eap and Ecp, respectively) and the ∆Ep value. Tx exhibit the lowest Eap value (0.123 V) and smallest ∆Ep (0.076 V) (entry 1 Table 3) while HQSAc presents Eap and ∆Ep values of 0.367 and 0.273 V, respectively (entry 5 Table 3). However, oxazines 1 and 2 have oxidation potentials were higher than Tx and HQSAc, and a ∆Ep close to 1 V (entries 2 and 3, as seen in Table 3). These results indicate that the glassy carbon working electrode surface is less reactive for the heterogeneous redox processes of oxazine 1 as well as 2, presenting a kind of limitation in comparison with those of the reference compounds.
All these results are in agreement with the ARP values obtained from the DPPH● tests (where the reaction response increases in the same order: oxazines << HQSAc < AAc < Tx). These results are also supported by the evidence previously reported [48,49,50], where the reaction with DPPH● behaves like an ET reaction, instead of the typical HAT mechanism, under our reaction conditions.
In summary, this study demonstrated the in vitro antioxidant capacity of two derivatives of oxazine (compounds 1 and 2), at concentrations of 9.0 µg/mL, 13.5 µg/mL, 18.0 µg/mL, 22.5 µg/mL and 27.0 µg/mL by the test of inhibition of OH●, ABTS●+ and AChE. The antioxidant capacity was confirmed ex vivo by the test of inhibition of hemolysis induced by AAPH in rat erythrocytes. However, these compounds have a limited response to some assays as it was demonstrated through cyclic voltammetry experiments and DPPH assays.
In addition, although the final products of the redox reaction of oxazines 1 and 2 have not been elucidated, a tentative radical inhibition mechanism is provided in the Scheme 1 based in our experimental results. As it is possible to see, when the oxidation reaction is performed in polar protic solvents, the DPPH● is unable to react by both a HAT, due to steric reasons, or ET for having a high oxidation potential, near to 1V. However, when oxazines are exposed to react with radical species like ABTS●+ or HO●, the radical inhibition reaction occurs via ET, being the imine moiety (>C=N-Ph) oxidized. In this way, the radical cation (Z●+) is formed and under go through a dimerization reaction (with one Y● reduced by oxazine) or a complexation reaction (with a stoichiometry 2:1), yielding 3 and 4 as final products.
It must be emphasized that in the case of ABTS●+ the stoichiometric values do not completely explain the proposed mechanism. If the reaction takes place only through the mechanism with Y● coupling path as last step, the number of ABTS●+ reduced should be 2. Nevertheless, the number of radical reduced are 1.1 and 1.5 for oxazines 1 and 2, respectively (entries 2 and 3 Table 3). This fact probably indicates that oxazine 1 has principally dimerization reaction as last step while oxazine 2 appears to follow the two different end pathways in Scheme 1. To support our hypotheses, it would be interesting to characterize the reaction products using liquid or gas chromatograph coupled with a mass spectrometer.

5. Conclusions

In summary, in vitro and ex vivo methods demonstrated that cyclohexene-fused 1,3-oxazines 1 and 2 have a potential antioxidant capacity compared with the classical reference compounds. This is an initial screening for determining the pharmacological potential of these substances as sources of active compounds with antioxidant properties.
Despite the fact that the mechanism and the antioxidant potential of these substances were elucidated with the help of different techniques, further studies should be performed to generalize the activities observed. In this sense, new chemical, pharmacological and biotechnological studies are needed in order to support the feasibility of using these substances for quenching free radicals and to obtain detailed structure-activity relationships for these compounds.

Author Contributions

Validation of the techniques and investigation was performed by G.F. and M.L.R. as well as the experimental evaluation of in vitro antioxidant potential by inhibition of DPPH radical and determination of redox potential. In addition, evaluation of in vitro antioxidant potential measured against the production of hydroxyl radical, by inhibition of ABTS●+ radical, by qualitative inhibition of the enzyme acetylcholinesterase and inhibition in erythrocytes of Rattus norvegicus were performed by M.S.F., M.d.R.M.d.B., A.P.S.C.L.S. and J.P.C. Formal analysis by M.S.F. and G.A.A.; project administration, resources, writing—original draft preparation, writing—review and editing by W.J.P., G.A.A. and Z.S.; visualization and supervision by M.C.R. and W.J.P.; funding acquisition by Z.S. and F.F.

Funding

This research was partially funded by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil. The work at the Instituto de Investigaciones en Fisicoquímica de Córdoba (INFIQC) was supported by Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET grant number: PIP 11220170100423CO), Fondo para la Investigación Científica y Tecnológica (FONCyT grant number: PICT-2017-1555) and Secretaría de Ciencia y Tecnología (SeCyT -UNC grant number: SeCyT-Nº411/18).

Acknowledgments

G.F., M.S.F. and M.L.R. want to thank CONICET for the fellowships granted.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Machado, K.C.; Oliveira, G.L.S.; De Sousa, É.B.V.; Costa, I.H.F.; Machado, K.C.; De Sousa, D.P.; Satyal, P.; De Freitas, R.M. Spectroscopic studies on the in vitro antioxidant capacity of isopentyl ferulate. Chem.-Biol. Interact. 2015, 225, 47–53. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Sukhorukov, A.Y.; Nirvanappa, A.C.; Swamy, J.; Ioffe, S.L.; Swamy, S.N.; Basappa; Rangappa, K.S. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase. Bioorg. Med. Chem. Lett. 2014, 24, 3618–3621. [Google Scholar] [CrossRef] [PubMed]
  3. Mendes de Freitas, R.; Da Silva Oliveira, G.L.; De Asevedo Mendes de Oliveira, F.R.; Oliveira Barros de Alencar, M.V.; Gomes Junior, A.L.; Araujo de Souza, A.; De Carvalho Melo Cavalcante, A.A. Evaluation of antioxidant capacity of the aqueous extract of Cynara scolymus L. (Asteraceae) in vitro and in Saccharomyces cerevisiae. Afr. J. Pharm. Pharmacol. 2014, 7, 136–147. [Google Scholar] [CrossRef]
  4. Alves, C.Q.; David, J.M.; David, J.P.; Bahia, M.V.; Aguiar, R.M. Methods for determination of in vitro antioxidant activity for extracts and organic compounds. Quím. Nova. 2010, 33, 2202–2210. [Google Scholar] [CrossRef]
  5. Ahmadi, F.; Sadeghi, S.; Modarresi, M.; Abiri, R.; Mikaeli, A. Chemical composition, in vitro anti-microbial, antifungal and antioxidant activities of the essential oil and methanolic extract of Hymenocrater longiflorus Benth., of Iran. Food Chem. Toxicol. 2010, 48, 1137–1144. [Google Scholar] [CrossRef] [PubMed]
  6. Abad, L.V.; Relleve, L.S.; Racadio, C.D.T.; Aranilla, C.T.; De la Rosa, A.M. Antioxidant activity potential of gamma irradiated carrageenan. Appl. Radiat. Isot. 2013, 79, 73–79. [Google Scholar] [CrossRef] [PubMed]
  7. Niki, E. Assessment of antioxidant capacity in vitro and in vivo. Free Radic. Biol. Med. 2010, 49, 503–515. [Google Scholar] [CrossRef] [PubMed]
  8. Rohenkohl, C.C.; Carniel, A.P.; Colpo, E. Consumo de antioxidantes durante tratamento quimioterápico. ABCD Arq. Bras. Cir. Dig. (São Paulo) 2011, 24, 107–112. [Google Scholar] [CrossRef]
  9. Barbosa, K.B.F.; Costa, N.M.B.; Alfenas, R.C.G.; De Paula, S.O.; Minim, V.P.R.; Bressan, J. Estresse oxidativo: Conceito, implicações e fatores modulatórios. Rev. Nutr. 2010, 23, 629–643. [Google Scholar] [CrossRef]
  10. Nogueira Neto, J.D.; De Almeida, A.A.C.; Da Silva Oliveira, J.; Dos Santos, P.S.; De Sousa, D.P.; De Freitas, R.M. Antioxidant effects of nerolidol in mice hippocampus after open field test. Neurochem. Res. 2013, 38, 1861–1870. [Google Scholar] [CrossRef]
  11. Ansari, N.; Khodagholi, F.; Amini, M. 2-Ethoxy-4,5-diphenyl-1,3-oxazine-6-one activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal death. Eur. J. Pharmacol. 2011, 658, 84–90. [Google Scholar] [CrossRef] [PubMed]
  12. Kalirajan, R.; Kulshrestha, V.; Sankar, S.; Jubie, S. Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors. Eur. J. Med. Chem. 2012, 56, 217–224. [Google Scholar] [CrossRef] [PubMed]
  13. Parlman, R.M.; Burns, L.D. Substituted Dihydro Oxazines as Hydrocarbon Antioxidants. U.S. Patent 4,313,738, 2 February 1982. [Google Scholar]
  14. Fülöp, F.; Bernáth, G.; Csirinyi, G. Synthesis of stereoisomers 2-phenylimino-3, 1-perhydro-benzoxazines and 3, 1-perhydrobenzothiazines. Org. Prep. Proced. Int. 1988, 20, 73–82. [Google Scholar] [CrossRef]
  15. Fülöp, F.; Bernáth, G.; Pihlaja, K. Synthesis, Stereochemistry and Transformations of Cyclopentane-, Cyclohexane-, Cycloheptane-, and Cyclooctane-Fused 1,3-Oxazines, 1,3-Thiazines, and Pyrimidines. Adv. Heterocycl. Chem. 1997, 69, 349–477. [Google Scholar] [CrossRef]
  16. Peláez, W.J.; Szakonyi, Z.; Fülöp, F.; Yranzo, G.I. Flash vacuum pyrolysis (fvp) of some hexahydroquinazolin-4(1H)-ones. Tetrahedron 2008, 64, 1049–1057. [Google Scholar] [CrossRef]
  17. Peláez, W.J.; Iriarte, A.G.; Szakonyi, Z.; Fülöp, F.; Argüello, G.A. Theoretical and experimental study on the reaction route for the FVP of 2-thioxohexahydroquinazolinones. J. Anal. Appl. Pyrolysis. 2012, 96, 181–187. [Google Scholar] [CrossRef]
  18. Iriarte, A.G.; Peláez, W.J.; Fülöp, F.; Argüello, G.A. Vibrational spectra of solid cis- and trans-2-thioxohexahydroquinazolin-4(1H)-one and theoretical calculations towards the interpretation of its thermal reactivity. RSC Adv. 2015, 5, 43345–43352. [Google Scholar] [CrossRef]
  19. De Brito, M.R.M.; Peláez, W.J.; Faillace, M.S.; Militão, G.C.G.; Almeida, J.R.G.S.; Argüello, G.A.; Szakonyi, Z.; Fülöp, F.; Salvadori, M.C.; Teixeira, F.S.; et al. Cyclohexene-fused 1,3-oxazines with selective antibacterial and antiparasitic action and low cytotoxic effects. Toxicol. Vitro. 2017, 44, 273–279. [Google Scholar] [CrossRef]
  20. Sawant, R.L.; Bhangale, L.; Wadekar, J.; Gaikwad, P. Substituent selection for design and synthesis of antimicrobial 1,3 oxazines: A topliss modified approach. Farmacia 2012, 60, 32–39. [Google Scholar]
  21. Sawant, R.L.; Mhaske, M.S.; Wadekar, J.B. Anticoagulant potential of Schiff bases of 1,3-oxazines. Int. J. PharmTech Res. 2012, 4, 320–323. [Google Scholar]
  22. Didwagh, S.S.; Piste, P.B. Novel one-pot Synthesis and Antimicrobial Activity of derivatives. Int. J. ChemtTech Res. 2013, 5, 2199–2203. [Google Scholar]
  23. Mathew, B.P.; Kumar, A.; Sharma, S.; Shukla, P.K.; Nath, M. An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives. Eur. J. Med. Chem. 2010, 45, 1502–1507. [Google Scholar] [CrossRef] [PubMed]
  24. Sindhu, T.; Arikkatt, S.; Vincet, G.; Chandran, M.; Bhat, A.; Krishnakumar, K. Biological activities of oxazine and its derivatives. Int. J. Pharma Sci. Res. (IJPSR) 2013, 4, 134–143. [Google Scholar]
  25. Fülöp, F.; Szakonyi, Z.; Pallai, V.P. 1,3-Heterocycles Condensed with Monoterpene Skeleton, Their Use and Pharmaceutical Compositions Comprising Such Compounds. WO2010070365A1 (81), 24 June 2010. [Google Scholar]
  26. Huang, D.; Boxin, O.U.; Prior, R.L. The chemistry behind antioxidant capacity assays. J. Agric. Food Chem. 2005, 53, 1841–1856. [Google Scholar] [CrossRef]
  27. Apak, R.; Gorinstein, S.; Böhm, V.; Schaich, K.M.; Özyürek, M.; Güçlü, K. Methods of measurement and evaluation of natural antioxidant capacity/activity (IUPAC Technical Report). Pure Appl. Chem. 2013, 85, 957–998. [Google Scholar] [CrossRef] [Green Version]
  28. Antolovich, M.; Prenzler, P.D.; Patsalides, E.; McDonald, S.; Robards, K. Methods for testing antioxidant activity. Analyst. 2002, 127, 183–198. [Google Scholar] [CrossRef]
  29. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef]
  30. Lopes, G.K.B.; Schulman, H.M.; Hermes-Lima, M. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions (This study is dedicated to the memory of Botany Professor Luiz F.G. Labouriau (1921–1996).). Biochim. Biophys. Acta. 1999, 1472, 142–152. [Google Scholar] [CrossRef]
  31. Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci. Technol. 1995, 28, 25–30. [Google Scholar] [CrossRef]
  32. Rhee, I.K.; Van De Meent, M.; Ingkaninan, K.; Verpoorte, R. Screening for acetylcholinesterase inhibitors from amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. J. Chromatogr. A 2001, 915, 217–223. [Google Scholar] [CrossRef]
  33. Ellman, G.L.; Courtney, K.D.; Andres, V.; Featherstone, R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7, 88–95. [Google Scholar] [CrossRef]
  34. Pohanka, M. and Dobes, P. Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase. Int. J. Mol. Sci. 2013, 14, 9873–9882. [Google Scholar] [CrossRef] [PubMed]
  35. Ugartondo, V.; Mitjans, M.; Torres, J.L.; Vinardell, M.P. Biobased epicatechin conjugates protect erythrocytes and nontumoral cell lines from H2O2-induced oxidative stress. J. Agric. Food Chem. 2009, 57, 4459–4465. [Google Scholar] [CrossRef] [PubMed]
  36. Lopes de Mendonça, I. Coordinator of the Commission on Ethics in the Use of Animals (CEUA). 2016. Available online: https://ufpi.br/etica-em-experimentacao-animal (accessed on 12 June 2019).
  37. Arteaga, J.F.; Ruiz-Montoya, M.; Palma, A.; Alonso-Garrido, G.; Pintado, S.; Rodríguez-Mellad, J.M. Comparison of the simple cyclic voltammetry (CV) and DPPH assays for the determination of antioxidant capacity of active principles. Molecules 2012, 17, 5126–5138. [Google Scholar] [CrossRef]
  38. Jara-Palacios, M.J.; Escudero-Gilete, M.L.; Hernández-Hierro, J.M.; Heredia, F.J.; Hernanz, D. Cyclic voltammetry to evaluate the antioxidant potential in winemaking by-products. Talanta 2017, 165, 211–215. [Google Scholar] [CrossRef]
  39. Chevion, S.; Roberts, M.A.; Chevion, M. The use of cyclic voltammetry for the evaluation of antioxidant capacity. Free Radic. Biol. Med. 2000, 28, 860–870. [Google Scholar] [CrossRef]
  40. Miceli, M.; Roma, E.; Rosa, P.; Feroci, M.; Loreto, M.A.; Tofani, D.; Gasperi, T. Synthesis of Benzofuran-2-one derivatives and evaluation of their antioxidant capacity by comparing DPPH assay and cyclic voltammetry. Molecules 2018, 23, 710. [Google Scholar] [CrossRef]
  41. Sharma, V.; Jaiswal, P.K.; Saran, M.; Yadav, D.K.; Saloni; Mathur, M.; Swami, A.K.; Misra, S.; Kim, M.; Chaudhary, S. Discovery of C-3 Tethered 2-oxo-benzo[1,4]oxazines as Potent Antioxidants: Bio-Inspired Based Design, Synthesis, Biological Evaluation, Cytotoxic, and in Silico Molecular Docking Studies. Front. Chem. 2018, 6, 1–16. [Google Scholar] [CrossRef]
  42. Silva, C.G.; Herdeiro, R.S.; Mathias, C.J.; Panek, A.D.; Silveira, C.S.; Rodrigues, V.P.; Rennó, M.N.; Falcão, D.Q.; Cerqueira, D.M.; Minto, A.B.M.; et al. Evaluation of antioxidant activity of Brazilian plants. Pharmacol. Res. 2005, 52, 229–233. [Google Scholar] [CrossRef]
  43. Ani, V.; Varadaraj, M.C.; Naidu, K.A. Antioxidant and antibacterial activities of polyphenolic compounds from bitter cumin (Cuminum nigrum L.). Eur. Food Res. Technol. 2006, 224, 109–115. [Google Scholar] [CrossRef]
  44. Deng, J.; Cheng, W.; Yang, G. A novel antioxidant activity index (AAU) for natural products using the DPPH assay. Food Chem. 2011, 125, 1430–1435. [Google Scholar] [CrossRef]
  45. Reed, T.T. Lipid peroxidation and neurodegenerative disease. Free Radic. Biol. Med. 2011, 51, 1302–1319. [Google Scholar] [CrossRef] [PubMed]
  46. Jamialahmadi, K.; Arasteh, O.; Riahi, M.M.; Mehrid, S.; Riahi-Zanjani, B.; Karimi, G. Protective effects of glucosamine hydrochloride against free radical-induced erythrocytes damage. Environ. Toxicol. Pharmacol. 2014, 38, 212–219. [Google Scholar] [CrossRef] [PubMed]
  47. Girish, T.K.; Vasudevaraju, P.; Prasada Rao, U.J.S. Protection of DNA and erythrocytes from free radical induced oxidative damage by black gram (Vigna mungo L.) husk extract. Food Chem. Toxicol. 2012, 50, 1690–1696. [Google Scholar] [CrossRef] [PubMed]
  48. Foti, M.; Ruberto, G. Kinetic solvent effects on phenolic antioxidants determined by spectrophotometric measurements. J. Agric. Food Chem. 2001, 49, 342–348. [Google Scholar] [CrossRef] [PubMed]
  49. Xie, J.; Schaich, K.M. Re-evaluation of the 2,2-Diphenyl-1-picrylhydrazyl Free Radical (DPPH) Assay for Antioxidant Activity. J. Agric. Food Chem. 2014, 62, 4251–4260. [Google Scholar] [CrossRef] [PubMed]
  50. Foti, M. Use and Abuse of the DPPH● Radical. J. Agric. Food Chem. 2015, 63, 8765–8776. [Google Scholar] [CrossRef] [PubMed]
Antioxidants 08 00197 g001 550
Figure 1. cis-1-benzyl-N-phenyl-1,4,4a,5,8,8a-hexahydro-2H-benzo[d][1,3]oxazin-2-imine (1) and trans-N-phenyl-1,4,4a,5,8,8a-hexahydro-2H-benzo[d][1,3]oxazin-2-imine (2) prepared for this study and their different biological activities previously described. MCF-7: Michigan Cancer Foundation, type 7 human breast carcinoma cells; HEP-2: Human epithelial, type 2 human larynx carcinoma cells; NCI-H: National Cancer Institute, human lung carcinoma cells; S. mansoni: Schistosoma mansoni.
Figure 1. cis-1-benzyl-N-phenyl-1,4,4a,5,8,8a-hexahydro-2H-benzo[d][1,3]oxazin-2-imine (1) and trans-N-phenyl-1,4,4a,5,8,8a-hexahydro-2H-benzo[d][1,3]oxazin-2-imine (2) prepared for this study and their different biological activities previously described. MCF-7: Michigan Cancer Foundation, type 7 human breast carcinoma cells; HEP-2: Human epithelial, type 2 human larynx carcinoma cells; NCI-H: National Cancer Institute, human lung carcinoma cells; S. mansoni: Schistosoma mansoni.
Antioxidants 08 00197 g001
Antioxidants 08 00197 g002 550
Figure 2. Percentage of remaining hydroxyl radical (OH●).
Figure 2. Percentage of remaining hydroxyl radical (OH●).
Antioxidants 08 00197 g002
Antioxidants 08 00197 g003 550
Figure 3. Percentage of ABTS●+ remaining.
Figure 3. Percentage of ABTS●+ remaining.
Antioxidants 08 00197 g003
Antioxidants 08 00197 g004 550
Figure 4. Percentage of hemolysis inhibition induced by 2,2’-Azobis(2-amidinopropane) dihydrochloride (AAPH) in erythrocytes of Rattus norvegicus. PBS: Phosphate Buffered Saline.
Figure 4. Percentage of hemolysis inhibition induced by 2,2’-Azobis(2-amidinopropane) dihydrochloride (AAPH) in erythrocytes of Rattus norvegicus. PBS: Phosphate Buffered Saline.
Antioxidants 08 00197 g004
Antioxidants 08 00197 g005 550
Figure 5. (A) Cyclic voltammograms for 5.0 × 10−4 M (a) Tx, (b) AAc, (c) HQSAc, and 1.0 × 10−3 M (d) oxazine 1 and (e) oxazine 2 at a bare glassy carbon electrodes (GCE); (B) Cyclic voltammograms for 1.0 × 10−3 M (a) oxazine 1 and (b) oxazine 2 in a deoxygenated solution at a bare GCE. Supporting electrolyte: 0.050 M phosphate buffer solution pH 7.40. Scan rate: 0.100 V s−1.
Figure 5. (A) Cyclic voltammograms for 5.0 × 10−4 M (a) Tx, (b) AAc, (c) HQSAc, and 1.0 × 10−3 M (d) oxazine 1 and (e) oxazine 2 at a bare glassy carbon electrodes (GCE); (B) Cyclic voltammograms for 1.0 × 10−3 M (a) oxazine 1 and (b) oxazine 2 in a deoxygenated solution at a bare GCE. Supporting electrolyte: 0.050 M phosphate buffer solution pH 7.40. Scan rate: 0.100 V s−1.
Antioxidants 08 00197 g005
Antioxidants 08 00197 g006 550
Figure 6. Reaction respond curves and rEC50 determined by inhibition of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. (a) Trolox; (b) AAc; (c) HQSAc and (d) Oxazine 1.
Figure 6. Reaction respond curves and rEC50 determined by inhibition of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. (a) Trolox; (b) AAc; (c) HQSAc and (d) Oxazine 1.
Antioxidants 08 00197 g006
Antioxidants 08 00197 sch001 550
Scheme 1. Reaction mechanism proposed for the radicals inhibition via ET by oxazines 1,2 in polar protic solvents. PSH: Polar protic solvents; EtOH: ethanol; ET: Electron Transfer process; Z●+: Radical cation intermediate.
Scheme 1. Reaction mechanism proposed for the radicals inhibition via ET by oxazines 1,2 in polar protic solvents. PSH: Polar protic solvents; EtOH: ethanol; ET: Electron Transfer process; Z●+: Radical cation intermediate.
Antioxidants 08 00197 sch001
Table
Table 1. Antioxidant capacity of compounds 1, 2 and Tx against hydroxyl radical (OH●) radical.
Table 1. Antioxidant capacity of compounds 1, 2 and Tx against hydroxyl radical (OH●) radical.
CompoundAntioxidant Capacity (%)
9.0 μg mL−113.5 μg mL−118.0 μg mL−122.5 μg mL−127.0 μg mL−1
171 ± 376.4 ± 0.276.9 ± 0.177.8 ± 0.178.5 ± 0.3
269.1 ± 0.379.2 ± 0.179.2 ± 0.379.4 ± 0.279.6 ± 0.1
Trolox24 ± 140.3 ± 0.360 ± 562 ± 682 ± 2
Table
Table 2. Antioxidant capacity of compounds 1, 2 and Tx against OH● radical.
Table 2. Antioxidant capacity of compounds 1, 2 and Tx against OH● radical.
CompoundAntioxidant Capacity (%)
9.0 μg mL−113.5 μg mL−118.0 μg mL−122.5 μg mL−127.0 μg mL−1
132.0 ± 0.436.4 ± 139.8 ± 0.442 ± 140.8 ± 0.5
238 ± 346 ± 446 ± 246 ± 146.6 ± 0.2
Trolox38 ± 136.5 ± 0.537.7 ± 0.341.0 ± 0.641.3 ± 0.6
Table
Table 3. Spectroscopic and Voltammetric analysis of different compounds.
Table 3. Spectroscopic and Voltammetric analysis of different compounds.
EntryCompoundSpectroscopic AnalysisVoltammetric Analysis
DPPH●ABTS●+CV
rEC50ARPN° of reduced DPPH●rEC50ARPN° of reduced ABTS●+Eap (V)Ecp (V)∆Ep(V) = |Ecp − Eap|
1Trolox0.2044.92.40.303.31.60.1230.0470.076
210000.452.21.10.420−0.5590.979
320000.342.91.50.380−0.5590.939
4AAc a0.2274.42.2-- b-- b-- b0.322-- c-- c
5HQSAc a0.2793.61.8-- b-- b-- b0.367−0.0940.273
a These experiments were performed in order to check the negative results obtained with the oxazines 1 and 2. b No ABTS●+ tests were performed with AAc and HQSAc. c None reversible process was observed. CV: cyclic voltammetry; Eap: anodic peak potential; Ecp: cathodic peak potential.

Share and Cite

MDPI and ACS Style

Firpo, G.; Ramírez, M.L.; Faillace, M.S.; de Brito, M.d.R.M.; e Silva, A.P.S.C.L.; Costa, J.P.; Rodríguez, M.C.; Argüello, G.A.; Szakonyi, Z.; Fülöp, F.; et al. Evaluation of the Antioxidant Activity of Cis/Trans-N-Phenyl-1,4,4a,5,8,8a-Hexahydro-3,1-Benzoxazin-2-Imines. Antioxidants 2019, 8, 197. https://doi.org/10.3390/antiox8060197

AMA Style

Firpo G, Ramírez ML, Faillace MS, de Brito MdRM, e Silva APSCL, Costa JP, Rodríguez MC, Argüello GA, Szakonyi Z, Fülöp F, et al. Evaluation of the Antioxidant Activity of Cis/Trans-N-Phenyl-1,4,4a,5,8,8a-Hexahydro-3,1-Benzoxazin-2-Imines. Antioxidants. 2019; 8(6):197. https://doi.org/10.3390/antiox8060197

Chicago/Turabian Style

Firpo, Guadalupe, María L. Ramírez, Martín S. Faillace, Maria dos R. Mendes de Brito, Ana P. S. Correia Lima e Silva, Jessica Pereira Costa, Marcela C. Rodríguez, Gustavo A. Argüello, Zsolt Szakonyi, Ferenc Fülöp, and et al. 2019. "Evaluation of the Antioxidant Activity of Cis/Trans-N-Phenyl-1,4,4a,5,8,8a-Hexahydro-3,1-Benzoxazin-2-Imines" Antioxidants 8, no. 6: 197. https://doi.org/10.3390/antiox8060197

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop